Skip to main content
Log in

Vasodilation effect of 2-benzyl-5-hydroxy-6-methoxy-3, 4-dihydroisoquinolin-1-one

  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

A 2-Benzyl-5-hydroxy-6-methoxy-3, 4-dihydroisoquinolin-1-one (ZC2) is a newly synthesized isoquinolinone compound. Its effect on vasodilation was evaluated in the present study. Isometric tension of rat artery rings was recorded by a sensitive myography system in vitro. The results showed that ZC2 relaxed rat mesenteric arteries pre-contracted by KCl, phenylephrine and 9, 11- dideoxy- 11α, 9α-epoxymethano-prostaglandin F2α (U46619), and abdominal aorta pre-contracted by KCl in a concentration-dependent manner. The ZC2-induced vasodilation was not affected by an endothelium denudation. ZC2 rightwards shifted the concentration-contraction curves, induced by KCl, phenylephrine, and 5-hydroxytryptamine (5-HT) in a non-parallel manner, which suggests that the vasodilation effects are most likely via voltage-dependent calcium channel (VDCC) and receptor-operated calcium channel (ROCC). Moreover, in Ca2+-free medium, ZC2 concentration-dependently depressed the vasoconstrictions induced by phenylephrine and CaCl2, and decreased a contractile response induced by caffeine, which indicates a role of extracellular Ca2+ influx inhibition through VDCC and ROCC, and intracellular Ca2+ release from Ca2+ store via the ryanodine receptors. Glibenclamide did not affect the vasodilation induced by ZC2, suggesting that ATP sensitive potassium channel is not involved in the vasodilation. The results indicate that ZC2 induces vasodilation by inhibiting the VDCC and ROCC, and receptormediated Ca2+ influx and release. The inhibition of intracellular Ca2+ release may be mediated via the ryanodine receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Ahn, H. Y., Karaki, H., and Urakawa, N., Inhibitory effects of caffeine on contractions and calcium movement in vascular and intestinal smooth muscle. Br. J. Pharmacol., 93, 267–274 (1988).

    Article  PubMed  CAS  Google Scholar 

  • Cao, Y. X., Zhang, W., He, J. Y., He, L. C., and Xu, C. B., Ligustilide induces vasodilatation via inhibiting voltage dependent calcium channel and receptor-mediated Ca2+ influx and release. Vascul. Pharmacol., 45, 171–176 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Cao, Y. X., Zheng, J. P., He, J. Y., Li, J., Xu, C. B., and Edvinsson, L., Induces vasodilatation of rat mesenteric artery in vitro mainly by inhibiting receptor-mediated Ca2+-influx and Ca2+-release. Arch. Pharm. Res., 28, 709–715 (2005).

    Article  PubMed  CAS  Google Scholar 

  • Chen, J. J., Chang, Y. L., Teng, C. M., and Chen, I. S., Vasorelaxing and antioxidant constituents from Hernandia nymphaeifolia. Planta. Med., 67, 593–598 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Cheng, Y., Ndisang, J. F., Tang, G., Cao, K., and Wang, R., Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. Am. J. Physiol. Heart Circ. Physiol., 287, H2316–H2323 (2004).

    Article  PubMed  CAS  Google Scholar 

  • Eu, J. P., Xu, L., Stamler, J. S., and Meissner, G., Regulation of ryanodine receptors by reactive nitrogen species. Biochem. Pharmacol., 57, 1079–1084 (1999).

    Article  PubMed  CAS  Google Scholar 

  • He, J. Y., Zhang, W., He, L. C., and Cao, Y. X., Imperatorin induces vasodilatation possibly via inhibiting voltage dependent calcium channel and receptor-mediated Ca2+influx and release. Eur. J. Pharmacol., 573, 170–175 (2007).

    Article  PubMed  CAS  Google Scholar 

  • Leijten, P. A. and van Breemen, C., The effects of caffeine on the noradrenaline-sensitive calcium store in rabbit aorta. J. Physiol., 357, 327–339 (1984).

    PubMed  CAS  Google Scholar 

  • Li, Q., Zhang, S. Q., Wang, S. C., and Zhou, M. Z., Efficient synthesis of thalifoline and its analogs. Synthetic Commun., 39, 1752–1758 (2009).

    Article  CAS  Google Scholar 

  • Lin, M. J., Yang, X. R., Cao, Y. N., and Sham, J. S., Hydrogen peroxide-induced Ca2+ mobilization in pulmonary arterial smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol., 292, L1598–L1608 (2007).

    Article  PubMed  CAS  Google Scholar 

  • Pellicciari, R., Camaioni, E., Costantino, G., Formentini, L., Sabbatini, P., Venturoni, F., Eren, G., Bellocchi, D., Chiarugi, A., and Moroni, F., On the way to selective PARP-2 inhibitors. Design, synthesis, and preliminary evaluation of a series of isoquinolinone derivatives. ChemMedChem, 3, 914–923 (2008).

    Article  PubMed  CAS  Google Scholar 

  • Roth, J., Madoux, F., Hodder, P., and Roush, W. R., Synthesis of small molecule inhibitors of the orphan nuclear receptor steroidogenic factor-1 (NR5A1) based on isoquinolinone scaffolds. Bioorg. Med. Chem. Lett., 18, 2628–2632 (2008).

    Article  PubMed  CAS  Google Scholar 

  • Shimoda, L. A. and Undem, C., Interactions between calcium and reactive oxygen species in pulmonary arterial smooth muscle responses to hypoxia. Respir. Physiol. Neurobiol., 174, 221–229 (2010).

    Article  PubMed  CAS  Google Scholar 

  • Sun, T., Liu, R., and Cao, Y. X., Vasorelaxant and antihypertensive effects of formononetin through endothelium-dependent and independent mechanisms. Acta Pharmacol. Sin., 32, 1009–1018 (2011).

    Article  PubMed  CAS  Google Scholar 

  • Zhang, S., Li, Q., Zhu, L., Cao, Y., Liu, R., and Chen, Z., Synthesis and vasodilatation of 2-Substituted-3, 4-dihydro-1(2H)-isoquinolinones. Chin. J. Org. Chem., 29, 966–970 (2009).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yong-Xiao Cao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xu, WQ., Xiong, ZZ., Chen, TT. et al. Vasodilation effect of 2-benzyl-5-hydroxy-6-methoxy-3, 4-dihydroisoquinolin-1-one. Arch. Pharm. Res. 35, 1471–1477 (2012). https://doi.org/10.1007/s12272-012-0818-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-012-0818-z

Key words

Navigation